Applied Therapeutics Inc (NASDAQ: APLT) kicked off on Friday, up 22.82% from the previous trading day, before settling in for the closing price of $0.49. Over the past 52 weeks, APLT has traded in a range of $0.29-$10.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -19.09%. While this was happening, its average annual earnings per share was recorded 27.48%. With a float of $113.02 million, this company’s outstanding shares have now reached $141.58 million.
Let’s determine the extent of company efficiency that accounts for 35 employees. In terms of profitability, gross margin is 24.15%, operating margin of -41030.19%, and the pretax margin is -16419.25%.
Applied Therapeutics Inc (APLT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Applied Therapeutics Inc is 21.81%, while institutional ownership is 75.01%. The most recent insider transaction that took place on Mar 04 ’25, was worth 4,561. In this transaction Chief Medical Officer of this company sold 10,366 shares at a rate of $0.44, taking the stock ownership to the 890,409 shares. Before that another transaction happened on Mar 04 ’25, when Company’s insider sold 14,502 for $0.44, making the entire transaction worth $6,381. This insider now owns 390,459 shares in total.
Applied Therapeutics Inc (APLT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 27.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.56% during the next five years compared to 26.57% growth over the previous five years of trading.
Applied Therapeutics Inc (NASDAQ: APLT) Trading Performance Indicators
Take a look at Applied Therapeutics Inc’s (APLT) current performance indicators. Last quarter, stock had a quick ratio of 3.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 316.15.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.43, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Applied Therapeutics Inc (APLT)
Looking closely at Applied Therapeutics Inc (NASDAQ: APLT), its last 5-days average volume was 3.31 million, which is a jump from its year-to-date volume of 3.14 million. As of the previous 9 days, the stock’s Stochastic %D was 89.73%. Additionally, its Average True Range was 0.06.
During the past 100 days, Applied Therapeutics Inc’s (APLT) raw stochastic average was set at 44.30%, which indicates a significant decrease from 87.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 121.30% in the past 14 days, which was higher than the 105.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4460, while its 200-day Moving Average is $3.5967. However, in the short run, Applied Therapeutics Inc’s stock first resistance to watch stands at $0.6636. Second resistance stands at $0.7243. The third major resistance level sits at $0.8106. If the price goes on to break the first support level at $0.5166, it is likely to go to the next support level at $0.4303. Now, if the price goes above the second support level, the third support stands at $0.3696.
Applied Therapeutics Inc (NASDAQ: APLT) Key Stats
The company with the Market Capitalisation of 85.36 million has total of 141,576K Shares Outstanding. Its annual sales at the moment are 460 K in contrast with the sum of -105,620 K annual income. Company’s last quarter sales were recorded 120 K and last quarter income was -68,590 K.
